Financial News

Nicox to present at the 30th Annual Piper Jaffray Healthcare conference

Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that Michele Garufi, Chairman and Chief Executive Officer of Nicox, will present at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday November 27, 2018 at 11:30 am ET. The conference is being held at the Lotte New York Palace in New York.

Read more

Nicox Postpones NASDAQ Listing Due to Market Volatility

Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that due to the extreme volatility of the financial markets, it has decided to postpone its dual listing on Nasdaq, concluding that it would not be in the interest of their existing shareholders at this time. The purpose of a Nasdaq listing is to allow the extensive U.S.

Read more

Nicox Third Quarter 2018 Business Update and Financial Highlights

  • NCX 470 Phase 2 clinical study initiated in Q3 2018 for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
  • Net revenue from VYZULTA┬« sales increased by 66% compared to Q2 2018

Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company,

Read more
More news